May 10 |
Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
|
May 10 |
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
|
May 9 |
Annovis Bio to post late-stage data for Parkinson's drug in June
|
May 9 |
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
|
May 9 |
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
|
May 9 |
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
|
May 8 |
Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates
|
May 8 |
Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues
|
May 7 |
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
|
May 6 |
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
|